Literature DB >> 27981705

Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.

Eva Altmann1, Paul Erbel1, Martin Renatus1, Michael Schaefer1, Anita Schlierf1, Adelaide Druet1, Laurence Kieffer1, Mickael Sorge1, Keith Pfister1,2, Ulrich Hassiepen1, Matthew Jones1, Simon Ruedisser1, Daniela Ostermeier1, Bruno Martoglio1,3, Anne B Jefferson2,4, Jean Quancard1.   

Abstract

CSN5 is the zinc metalloprotease subunit of the COP9 signalosome (CSN), which is an important regulator of cullin-RING E3 ubiquitin ligases (CRLs). CSN5 is responsible for the cleavage of NEDD8 from CRLs, and blocking deconjugation of NEDD8 traps the CRLs in a hyperactive state, thereby leading to auto-ubiquitination and ultimately degradation of the substrate recognition subunits. Herein, we describe the discovery of azaindoles as a new class of CSN5 inhibitors, which interact with the active-site zinc ion of CSN5 through an unprecedented binding mode. The best compounds inhibited CSN5 with nanomolar potency, led to degradation of the substrate recognition subunit Skp2 in cells, and reduced the viability of HCT116 cells.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  CSN5; azaindoles; inhibitors; metalloproteases; ubiquitin ligases

Mesh:

Substances:

Year:  2016        PMID: 27981705     DOI: 10.1002/anie.201608672

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  8 in total

1.  Integrating multi-omics data reveals function and therapeutic potential of deubiquitinating enzymes.

Authors:  Laura M Doherty; Caitlin E Mills; Sarah A Boswell; Xiaoxi Liu; Charles Tapley Hoyt; Benjamin Gyori; Sara J Buhrlage; Peter K Sorger
Journal:  Elife       Date:  2022-06-23       Impact factor: 8.713

Review 2.  On the Study of Deubiquitinases: Using the Right Tools for the Job.

Authors:  Cody Caba; Azam Mohammadzadeh; Yufeng Tong
Journal:  Biomolecules       Date:  2022-05-14

3.  CSNAP, the smallest CSN subunit, modulates proteostasis through cullin-RING ubiquitin ligases.

Authors:  Maria G Füzesi-Levi; Irit Fainer; Radoslav Ivanov Enchev; Gili Ben-Nissan; Yishai Levin; Meital Kupervaser; Gilgi Friedlander; Tomer Meir Salame; Reinat Nevo; Matthias Peter; Michal Sharon
Journal:  Cell Death Differ       Date:  2019-07-31       Impact factor: 15.828

4.  COP9 signalosome subunit CSN5, but not CSN6, is upregulated in lung adenocarcinoma and predicts poor prognosis.

Authors:  Dakai Xiao; Shengli Yang; Liyan Huang; Huiming He; Hui Pan; Jianxing He
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

Review 5.  Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.

Authors:  Guohong Liu; Francois X Claret; Fuling Zhou; Yunbao Pan
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

Review 6.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.

Authors:  David J Sherman; Jing Li
Journal:  Molecules       Date:  2020-02-05       Impact factor: 4.411

7.  DRJAMM Is Involved in the Oxidative Resistance in Deinococcus radiodurans.

Authors:  Jianling Cai; Chaoming Pan; Ye Zhao; Hong Xu; Bing Tian; Liangyan Wang; Yuejin Hua
Journal:  Front Microbiol       Date:  2022-01-28       Impact factor: 5.640

Review 8.  Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease.

Authors:  Xin Pan; Sihua Wu; Wenping Wei; Zixuan Chen; Yong Wu; Kaizheng Gong
Journal:  Biomolecules       Date:  2022-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.